Last reviewed · How we verify
NCT06643559
The Effect of Cognitive Rehabilitation on Epileptic Pateints Under Treatment
NA trial testing cognitive rehabilitation in Cognitive Dysfunction in 368 participants. Completed in 1 August 2023.
1 July 2023
Quick facts
| Lead sponsor | Gulhane Training and Research Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 368 |
| Start date | 1 June 2022 |
| Primary completion | 1 July 2023 |
| Estimated completion | 1 August 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- cognitive rehabilitation
Conditions studied
- Cognitive Dysfunction — all drugs for Cognitive Dysfunction →
- Epilepsy — all drugs for Epilepsy →
Sponsor
Gulhane Training and Research Hospital
Who can join
Adults 18 to 50, any sex, with Cognitive Dysfunction or Epilepsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
It is clear that studies on cognitive rehabilitation in epilepsy patients mostly focus on patients undergoing epilepsy surgery and are largely classified according to the type of epilepsy. The main purpose of this study is to determine whether cognitive impairments associated with antiepileptic drugs develop in epilepsy patients using neuropsychological tests and event-related potentials, and if such an impairment is present, to investigate whether cognitive rehabilitation is beneficial.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06643559
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of cognitive rehabilitation
Trials testing the same drug.
- NCT06186661 — Multicontextual Treatment Approach in Stroke · NA · completed
Other recruiting trials for Cognitive Dysfunction
Currently open trials in the same condition.
- NCT07526740 — Brain Stimulation and Cognitive Training for MCI · NA · recruiting
- NCT07517237 — taVNS + CCT for Neurocognitive Rehab · NA · recruiting
- NCT07171450 — Cognitive Remediation · NA · recruiting
- NCT07418008 — The Liver Cirrhosis Cognitive Decline Scale (LiCCoS) · recruiting
- NCT07394504 — Effects of Turning Based Dual Task Training on Balance and Mild Cognitive Impairment in Diabetic Peripheral Neuropathy · NA · recruiting
Other Gulhane Training and Research Hospital trials
Trials by the same sponsor.
- NCT07283588 — İntensive Care Sepsis Prevelance in Turkey (INSEP-TURK) · active not recruiting
- NCT07145554 — f-ESWT vs Steroid Injection for Piriformis Syndrome · NA · completed
- NCT07039370 — Molecular Signatures of TMS Response in Treatment-Resistant Depression · NA · recruiting
- NCT06995222 — The Role of Renal Resistive Index (RI) in Predicting Acute Kidney Injury Progression in Intensive Care Clinic · recruiting
- NCT06765031 — The Role of Furosemide Stress Test in the Intensive Care Clinic · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06643559 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gulhane Training and Research Hospital
- Last refreshed: 16 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06643559.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing